Ten Seeger Weiss Attorneys Named To The 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers Guide

Seeger Weiss is proud to announce that ten Seeger Weiss attorneys have been selected for inclusion in The 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers guide.

March 30, 2026

Lawdragon 500 Leading Plaintiff Financial Lawyers

Seeger Weiss is proud to announce that ten Seeger Weiss attorneys have been selected for inclusion in The 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers guide.

Congratulations to Christopher Seeger, Stephen Weiss, Parvin K. Aminolroaya, Ben Barnett, David R. Buchanan, Steven Daroci, Shauna Itri, Jeremy Kasha, Jennifer Scullion, and Caleb Seeley on this well-deserved recognition.

This guide recognizes leading attorneys who secure justice and financial accountability for investors who have been defrauded, companies blocked from fair competition, and consumers whose rights have been trampled by corporations. The covered disciplines include securities litigation, antitrust and competition law, consumer fraud, data privacy, whistleblower and qui tam matters, and complex class action claims rooted in financial loss.

The recognized attorneys have taken on leadership roles in cases of national importance, holding corporations and institutions accountable for financial harm to consumers and investors.

Lawdragon’s selection methodology draws on more than 30 years of legal journalism and industry research. Their editorial team reviews thousands of candidates nationwide, evaluating legal skill, leadership, integrity, and a consistent record of results.

See the full guide here. The selection methodology can be found here.

No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More